首页> 美国卫生研究院文献>Oncology Letters >Lymph node ratio is a better prognosticator than lymph node status for gastric cancer: A retrospective study of 138 cases
【2h】

Lymph node ratio is a better prognosticator than lymph node status for gastric cancer: A retrospective study of 138 cases

机译:138例胃癌的回顾性研究比淋巴结状况更好的预后

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

To study the clinical significance of lymph node ratio (LNR) in gastric cancer (GC), this study analyzed 613 patients with GC who underwent surgical resection. Of 613 patients with GC, 138 patients who had >15 lymph nodes (LNs) resected and radical resection were enrolled into the final study. All major clinicopathological data were entered into a central database. LNR was defined as the ratio of the number of metastatic LNs to the number of removed LNs. In order to determine the best cut-off points for LNR, the log-rank test and X-tile were used. LNR was then substituted for lymph node status (pN) in the 7th American Joint Committee on Cancer tumor-node-metastases (TNM) staging system and this was defined as the tumor-node ratio-metastases (TRM) staging system. Pearson's correlation coefficient (r) was used to study the correlations among the number of removed LNs, pN and LNR. The Kaplan-Meier survival curve was used to study the survival status, and the log-rank test and Cox proportional hazards model were used to identify the independent factors for survival. Receiver operating characteristic curve analysis was used to determine the predictive value of the parameters. By the time of last follow-up (median follow-up period, 38.3 months; range, 9.9–97.7 months), the median overall survival (OS) was 23.9 months [95% confidence interval (CI), 18.8–29.0 months]. The 1-, 2-, 3- and 5-year survival rates were 76.8, 57.2, 50.0 and 46.4%, respectively. The cut-off points were 0, 0.5 and 0.8 (R0, LNR=0; R1, LNR ≤0.5; R2, 0.5> LNR ≤0.8; and R3, LNR >0.8). Univariate and multivariate analyses revealed that both LNR and pN were independent prognostic factors for GC. LNR could better differentiate OS in patients than LN. In addition, the TRM staging system was better at predicting the clinical outcomes than the TNM staging system, and LNR was better than pN. In conclusion, LNR was a better prognosticator than pN for GC.
机译:为了研究胃癌(GC)中淋巴结比率(LNR)的临床意义,本研究分析了613例行外科手术切除的GC患者。在613例GC患者中,有138例切除了15个以上淋巴结(LN)并进行根治性切除的患者被纳入了最终研究。所有主要临床病理数据均输入中央数据库。 LNR定义为转移性LN数量与去除的LN数量之比。为了确定LNR的最佳截止点,使用了对数秩检验和X-tile。然后,在第7届美国癌症肿瘤结节转移(TNM)分期联合委员会中,LNR代替了淋巴结状态(pN),这被定义为肿瘤结节比率转移(TRM)分期系统。皮尔逊相关系数(r)用于研究去除的LN,pN和LNR数量之间的相关性。使用Kaplan-Meier生存曲线研究生存状况,使用对数秩检验和Cox比例风险模型确定生存的独立因素。接收器工作特性曲线分析用于确定参数的预测值。到最后一次随访时(中位随访时间38.3个月;范围9.9–97.7个月),中位总生存期(OS)为23.9个月[95%置信区间(CI),18.8–29.0个月] 。 1年,2年,3年和5年生存率分别为76.8%,57.2%,50.0和46.4%。截止点为0、0.5和0.8(R0,LNR = 0; R1,LNR≤0.5; R2,0.5>LNR≤0.8;和R3,LNR> 0.8)。单因素和多因素分析表明,LNR和pN都是GC的独立预后因素。与LN相比,LNR可以更好地区分患者的OS。此外,TRM分期系统比TNM分期系统更能预测临床结果,而LNR优于pN。总之,对于GC,LNR比pN更好的预后。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号